Maria Nichol

Maria Nichol has a diverse and extensive work experience in the biotech industry. Maria is currently the VP of Business Development at Artax Biopharma Inc since April 2023. Prior to that, they worked as a Consultant and Managing Director at Compass IP Limited, where they specialized in helping biotech companies develop the right IP strategy to bring innovative therapeutics to market. Maria also served as the Head of IP at Agomab Therapeutics in 2022.

Before their role at Compass IP Limited, Maria had a long tenure at Galapagos, starting as a Consultant in IP and Business Development in March 2022 and later becoming the Vice President of IP. Maria'stime at Galapagos spanned from August 2006 to February 2022.

Maria also gained experience in the biotech industry through their role as a Non-Executive Board Member at Fibrocor Therapeutics in 2021. In addition, they worked as a K2 Network Attorney at K2 IP Ltd from January 2016 to December 2017.

Maria'searlier career includes positions such as IP Manager at Biotica Technology Limited and Patent Associate at Oxford Glycosciences, both in 2003.

Overall, Maria Nichol brings over 20 years of experience in IP strategy, business development, and leadership roles in the biotech industry.

Maria Nichol attended the University of Cambridge from 1994 to 1997, where they obtained a BA Hons degree in Natural Science. Maria then went on to pursue higher education at the University of Oxford from 1997 to 2001, completing their DPhil in Alzheimer's disease. In 2003 to 2007, Maria received CIPA / EQE training, although no degree or field of study is specified for this particular program.